Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|February 26, 2008
Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004)William DuMouchel, David Fram, Xionghu Yang, et al.
The Journal of Allergy and Clinical Immunology|June 22, 2018
NAVIGATE II: Randomized, double-blind trial of the exhalation delivery system with fluticasone for nasal polyposisDonald A Leopold, David Elkayam, John C Messina, et al.
Headache|May 13, 2017
Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered<sup>®</sup> Exhalation Delivery System (Sumatriptan Nasal Powder) vs Oral SumatriptanStephen Silberstein, Paul K Winner, Peter J McAllister, et al.
Acta Neuropsychiatrica|December 8, 2016
Reliability of basal plasma vasopressin concentrations in healthy male adultsDaniel S Quintana, Lars T Westlye, Knut T Smerud, et al.
International Forum of Allergy & Rhinology|June 2, 2018
EXHANCE-12: 1-year study of the exhalation delivery system with fluticasone (EDS-FLU) in chronic rhinosinusitisJames N Palmer, Kraig W Jacobson, John C Messina, et al.
Hormones and Behavior|May 12, 2018
Saliva oxytocin measures do not reflect peripheral plasma concentrations after intranasal oxytocin administration in menDaniel S Quintana, Lars T Westlye, Knut T Smerud, et al.
International Clinical Psychopharmacology|January 12, 2010
Psychometric evaluation of a Patient-Rated Most Troubling Symptom Scale for Depression: findings from a secondary analysis of a clinical trialGahan J Pandina, Georges M Garibaldi, Dennis A Revicki, et al.
American Journal of Rhinology & Allergy|November 28, 2018
NAVIGATE I: Randomized, Placebo-Controlled, Double-Blind Trial of the Exhalation Delivery System With Fluticasone for Chronic Rhinosinusitis With Nasal PolypsRaj Sindwani, Joseph K Han, Daniel F Soteres, et al.
Headache|October 31, 2014
A randomized, double-blind, placebo-controlled study of breath powered nasal delivery of sumatriptan powder (AVP-825) in the treatment of acute migraine (The TARGET Study)Roger K Cady, Peter J McAllister, Egilius L H Spierings, et al.
International Forum of Allergy & Rhinology|June 8, 2022
Efficacy of the exhalation delivery system with fluticasone in patients with chronic rhinosinusitis with nasal polyps whose symptoms recur after sinus surgeryRandall A Ow, Zachary M Soler, Raj Sindwani, et al.
Pageof 4